PROSPECTIVE-STUDY OF SURGICAL RESECTION OF DUODENAL AND PANCREATIC GASTRINOMAS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 16th Annual Meeting of the American-Association-of-Endocrine-Surgeons MacFarlane, M. P., FRAKER, D. L., Alexander, H. R., NORTON, J. A., Lubensky, I., Jensen, R. T. MOSBY-YEAR BOOK INC. 1995: 973–80


The role of surgical resection of gastrinoma in multiple endocrine neoplasia type 1 (MEN 1) is controversial because of low biochemical cure rates, but with adequate duodenal exploration higher cure rates may be possible.We have prospectively evaluated this proposal in ten consecutive patients with MEN 1 and Zollinger-Ellison syndrome who underwent surgical exploration for gastrinoma resection including a detailed evaluation of the duodenum by palpation, intraoperative endoscopy with transillumination, and duodenotomy.Duodenal tumors were present in seven patients. Six of seven patients had metastatic deposits in lymph nodes, and two of seven had synchronous pancreatic tumors. Three patients had a single duodenal tumor, one patient had two tumors, and three patients had more than 20 duodenal tumors. Positive gastrin staining by use of immunohistochemistry was seen in all duodenal tumors. None of these seven patients were biochemically cured. Of three patients with negative duodenal explorations, two had single pancreatic tumors removed and one had only lymph node gastrinoma. No patients were biochemically cured.Not all patients with MEN 1 and Zollinger-Ellison syndrome have duodenal gastrinomas. In the 70% of patients with duodenal tumors, even extensive duodenal exploration with removal of positive lymph nodes does not result in cures because 86% of tumors had metastasized to lymph nodes and 43% of patients had large numbers of tumors.

View details for Web of Science ID A1995TH94700009

View details for PubMedID 7491542